Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 11

Trial Status

Completed1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT06363292Phase 1Completed
Study to Evaluate the Safety and Tolerability of PRO-231 Versus VIGAMOXI® on the Ocular Surface of Healthy Subjects
Bacterial ConjunctivitisOphthalmological Agent Toxicity
StudydirectorStart date: 2024-01-30

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Regional Medical Affairs Manager

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Laura R Saucedo-Rodíguez, MD

Independent Clinical Research Center

Related
1 trials

Shared therapeutic areas:

Conjunctivitis, Bacterial

Worked with same sponsors:

Laboratorios Sophia S.A de C.V.
Similarity Score15%

José F Alaniz-De La O, MD

Independent Clinical Research Center

Related
1 trials

Shared therapeutic areas:

Conjunctivitis, Bacterial

Worked with same sponsors:

Laboratorios Sophia S.A de C.V.
Similarity Score15%

Leopoldo M Baiza-Durán, MD

Clinical Research Department. Laboratorios Sophia SA de CV

Related
3 trials

Shared therapeutic areas:

Conjunctivitis, Bacterial

Worked with same sponsors:

Laboratorios Sophia S.A de C.V.
Similarity Score15%

Leopoldo Baiza, MD

Laboratorios Sophia

Related
1 trials

Shared therapeutic areas:

Conjunctivitis, Bacterial

Worked with same sponsors:

Laboratorios Sophia S.A de C.V.
Similarity Score15%

Johnson Varughese

Valeant/Bausch & Lomb

Related
2 trials

Shared therapeutic areas:

Conjunctivitis, Bacterial
Similarity Score15%

Leopoldo Baiza Durán, MD

Laboratorios Sophia S.A de C.V.

Related
12 trials

Shared therapeutic areas:

Conjunctivitis, Bacterial

Worked with same sponsors:

Laboratorios Sophia S.A de C.V.
Similarity Score15%

Catherine Allaire, MD

Bausch & Lomb Incorporated

Related
1 trials

Shared therapeutic areas:

Conjunctivitis, Bacterial
Similarity Score15%

Rubens Belfort Jr., MD

Federal University of São Paulo / Hospital São Paulo

Related
1 trials

Shared therapeutic areas:

Conjunctivitis, Bacterial
Similarity Score15%

Steven J. Lichtenstein, M.D.

Investigator / Contact

Related
1 trials

Shared therapeutic areas:

Conjunctivitis, Bacterial
Similarity Score15%

Helen Yu, Lead CSM

Alcon Research

Related
1 trials

Shared therapeutic areas:

Conjunctivitis, Bacterial
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06363292Phase 1StudyDirector

Study to Evaluate the Safety and Tolerability of PRO-231 Versus VIGAMOXI® on the Ocular Surface of Healthy Subjects

Bacterial ConjunctivitisOphthalmological Agent Toxicity
Completed

All 1 trials loaded